Login to Your Account



R-Pharm Keeping Biotech Local

Russia Emerging from Behind Iron Curtain with Innovation

By Michael Harris
Senior Editor

Thursday, August 23, 2012
A string of first-ever events for Russia, including its official admittance to the World Trade Organization, plus committed government support to build a biopharma industry means the nation once known as the Kremlin may be in need of a more modern nickname as it transforms from an emerging market to one that could compete alongside the U.S., Japan and Europe.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription